Last reviewed · How we verify

NCT05891626

Group Intervention on Vaccine Confidence

Status unknown NA Last updated 10 October 2023
What this trial tests

NA trial testing Group intervention in Vaccination Refusal in 429 participants. Status unknown.

Timeline
2 August 2023
Primary endpoint
30 June 2024
31 December 2024

Quick facts

Lead sponsorMultiCare Health System Research Institute
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment429
Start date2 August 2023
Primary completion30 June 2024
Estimated completion31 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

MultiCare Health System Research Institute

Who can join

18 and older, any sex, with Vaccination Refusal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study has one primary objective and two secondary objectives, with an overall goal of understanding barriers to vaccination and vaccination confidence, so that effective interventional strategies can be further developed and tested to improve vaccination outcomes in a community healthcare setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Group intervention

Trials testing the same drug.

Other recruiting trials for Vaccination Refusal

Currently open trials in the same condition.

Other MultiCare Health System Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05891626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing